Amalia Issa
Chair, Department of Health Policy and Public Health
Founding Director, Program in Personalized Medicine & Targeted Therapeutics
Professor of Health Policy and Public Health
University of the Sciences,
USA
Amalia M. Issa, PhD, MPH, FCPP, is an internationally recognized scientist in the field of personalized genomic medicine. She is professor and chair of the Department of Health Policy and Public Health at the University of the Sciences in Philadelphia, and founding director of the Program in Personalized Medicine and Targeted Therapeutics. Dr. Issa has served or is serving as principal investigator on many funded projects, serves on editorial boards and in leadership positions in several professional associations, and is a reviewer for several scientific journals and national and international granting agencies.
Dr. Issa was among the first scientists to initiate translational research and publish on the policy-relevant issues of pharmacogenomics. She developed a unique area of translational research focused on pharmacogenomics and personalized genomic medicine applications, and their translation and integration into health care delivery and health systems. Her research is positioned at the nexus of epidemiology/health services research and molecular science. She leads an interdisciplinary team of scientists who are actively engaged in translating personalized genomic medicine research from the laboratory bench to the bedside, and to the community and policy.
Dr. Issa has numerous publications in peer-reviewed literature on pharmacogenomics and personalized medicine, pharmacoepidemiology, clinical pharmacology, neuropharmacology, and drug safety. She has received many awards and honours for her work. She holds degrees from McGill University (PhD in neuroscience) and the UCLA School of Public Health, and has completed fellowship training at Harvard Medical School.